MaxCyte (NASDAQ:MXCT) Rating Increased to Hold at Wall Street Zen
MaxCyte (NASDAQ:MXCT – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Sunday. MXCT has been the subject of a number of other reports. BTIG Research set a $6.00 price target on shares of […]
MaxCyte (NASDAQ:MXCT – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Sunday. MXCT has been the subject of a number of other reports. BTIG Research set a $6.00 price target on shares of […]
